Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8+ but not CD4+ T cells

被引:88
作者
Merritt, C
Enslen, H
Diehl, N
Conze, D
Davis, RJ
Rincón, M
机构
[1] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA
[2] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA
[3] Howard Hughes Med Inst, Worcester, MA 01605 USA
关键词
D O I
10.1128/MCB.20.3.936-946.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD4(+) and CD8(+) T cells play specific roles during an immune response. Different molecular mechanisms could regulate the proliferation, death, and effector functions of these two subsets of T cells. The p38 mitogen-activated protein (MAP) kinase pathway is induced by cytokines and environmental stress and has been associated with cell death and cytokine expression. Here me report that activation of the p38 MAP kinase pathway in vivo causes a selective loss of CD8(+) T cells due to the induction of apoptosis. In contrast, activation of p38 MAP kinase does not induce CD4(+) T-cell death. The apoptosis of CD8(+) T cells is associated with decreased expression of the antiapoptotic protein Bcl-2. Regulation of the p38 MAP kinase pathway in T cells is therefore essential for the maintenance of CD4/CD8 homeostasis in the peripheral immune system. Unlike cell death, gamma interferon production is regulated by the p38 MAP kinase pathway in bath CD4(+) and CD8(+) T cells, Thus, specific aspects of CD4(+) and CD8(+) T-cell function are differentially controlled by the p38 MAP kinase signaling pathway.
引用
收藏
页码:936 / 946
页数:11
相关论文
共 66 条
  • [51] 4-1BB costimulatory signals preferentially induce CD8(+) T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
    Shuford, WW
    Klussman, K
    Tritchler, DD
    Loo, DT
    Chalupny, J
    Siadak, AW
    Brown, TJ
    Emswiler, J
    Raecho, H
    Larsen, CP
    Pearson, TC
    Ledbetter, JA
    Aruffo, A
    Mittler, RS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 47 - 55
  • [52] Sohn SJ, 1998, J IMMUNOL, V160, P2130
  • [53] Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes
    Sugawara, T
    Moriguchi, T
    Nishida, E
    Takahama, Y
    [J]. IMMUNITY, 1998, 9 (04) : 565 - 574
  • [54] Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand
    Suzuki, I
    Fink, PJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) : 123 - 128
  • [55] DEFECTS IN B-LYMPHOCYTE MATURATION AND T-LYMPHOCYTE ACTIVATION IN MICE LACKING JAK3
    THOMIS, DC
    GURNIAK, CB
    TIVOL, E
    SHARPE, AH
    BERG, LJ
    [J]. SCIENCE, 1995, 270 (5237) : 794 - 797
  • [56] A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket
    Tong, L
    Pav, S
    White, DM
    Rogers, S
    Crane, KM
    Cywin, CL
    Brown, ML
    Pargellis, CA
    [J]. NATURE STRUCTURAL BIOLOGY, 1997, 4 (04) : 311 - 316
  • [57] VEIS DJ, 1993, J IMMUNOL, V151, P2546
  • [58] Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase
    Wang, XZ
    Ron, D
    [J]. SCIENCE, 1996, 272 (5266) : 1347 - 1349
  • [59] Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
    Waskiewicz, AJ
    Flynn, A
    Proud, CG
    Cooper, JA
    [J]. EMBO JOURNAL, 1997, 16 (08) : 1909 - 1920
  • [60] Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
    Whitmarsh, AJ
    Yang, SH
    Su, MSS
    Sharrocks, AD
    Davis, RJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) : 2360 - 2371